BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Anesthetics to Prevent Lung Injury in Cardiac Surgery

Phase 1

Completed

Conditions: Inflammatory Lung Injury
Ischemia-Reperfusion Lung Injury
Postoperative Pulmonary Complications

Interventions: Drug: Sevoflurane
Drug: Propofol

First Posted Date: 2016-09-29

Last Posted Date: 2021-05-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 51

Registration Number: NCT02918877

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Phase 2

Terminated

Conditions: Diabetes Complications
Diabetes Mellitus
Diabetic Neuropathies

Interventions: Drug: IGIV-C
Drug: 0.9% Sodium Chloride

First Posted Date: 2016-09-27

Last Posted Date: 2024-05-07

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 13

Registration Number: NCT02915263

Locations: 🇺🇸
Beth Israel Deaconness Medical Center, Boston, Massachusetts, United States

Prevention of Early Postoperative Decline

Not Applicable

Completed

Conditions: Postoperative Cognitive Dysfunction
Delirium

Interventions: Device: Lumosity

First Posted Date: 2016-09-21

Last Posted Date: 2020-06-16

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 45

Registration Number: NCT02908464

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

FGF21 and Fructose Challenge in Humans

Not Applicable

Completed

Conditions: Fasting

Interventions: Dietary Supplement: oral carbohydrate challenge

First Posted Date: 2016-08-31

Last Posted Date: 2023-08-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 50

Registration Number: NCT02884791

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

A Study to Evaluate Fecal Microbiota Transplantation Engraftment in IBS

Phase 1

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Procedure: fecal microbiota transplantation
Drug: placebo fecal microbiota transplantation
Procedure: FMT with antibiotic pre-treatment (v1)
Procedure: FMT with antibiotic pre-treatment (v2)

First Posted Date: 2016-07-28

Last Posted Date: 2019-12-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 80

Registration Number: NCT02847481

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older

Not Applicable

Terminated

Conditions: Estrogen Receptor Positive Breast Cancer
Breast Cancer
Node-negative Breast Cancer
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions: Other: Breast Cancer Treatment Decision Aid for women 70+
Other: Usual Care

First Posted Date: 2016-07-06

Last Posted Date: 2024-01-05

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 65

Registration Number: NCT02823262

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

Phase 2

Completed

Conditions: Hidradenitis Suppurativa

Interventions: Drug: 23.4% Hypertonic saline

First Posted Date: 2016-06-20

Last Posted Date: 2023-01-09

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 21

Registration Number: NCT02805595

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Effects of Open-label vs Double-blind Treatment in IBS

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome
Placebo Effect
Placebos
Peppermint Oil

Interventions: Dietary Supplement: peppermint oil
Drug: placebo

First Posted Date: 2016-06-16

Last Posted Date: 2024-01-22

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 340

Registration Number: NCT02802241

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients

Phase 2

Completed

Conditions: Liver Transplantation

Interventions: Biological: Interleukin-2

First Posted Date: 2016-04-15

Last Posted Date: 2022-12-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 7

Registration Number: NCT02739412

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury

Early Phase 1

Completed

Conditions: Acute Kidney Injury

Interventions: Drug: Oral niacinamide, 3 gram daily
Drug: Placebo
Drug: Oral niacinamide, 1 gram daily

First Posted Date: 2016-03-08

Last Posted Date: 2018-03-08

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 55

Registration Number: NCT02701127

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy